Sort
15,273 grants matching “antimicrobial resistance”
Unravelling lipid trafficking for the bacterial outer membrane
$423,750Damian Charles Ekiert · New York University School Of Medicine · R35 · FY2021 · GM
PROTEASOME-DEPENDENT DEGRADATION IN MYCOBACTERIUM TUBERCULOSIS
$423,750Katerina Heran Darwin · New York University School Of Medicine · R01 · FY2016 · AI
Unravelling lipid trafficking for the bacterial outer membrane
$423,750Damian Charles Ekiert · New York University School Of Medicine · R35 · FY2019 · GM
Unravelling lipid trafficking for the bacterial outer membrane
$423,750Damian Charles Ekiert · New York University School Of Medicine · R35 · FY2020 · GM
PROTEASOME-DEPENDENT DEGRADATION IN MYCOBACTERIUM TUBERCULOSIS
$423,750Katerina Heran Darwin · New York University School Of Medicine · R01 · FY2019 · AI
Virulence Regulation by the Mycobacterium tuberculosis Proteasome
$423,750Katerina Heran Darwin · New York University School Of Medicine · R01 · FY2017 · HL
Selective Modulation of Neutrophils in Critical Illness
$423,618Craig Thomas Lefort · Rhode Island Hospital · R35 · FY2024 · GM
Digital High Resolution Melt and Machine Learning for Rapid and Specific Diagnosis in Neonatal Sepsis
$423,601Stephanie Irene Fraley · University Of California, San Diego · R01 · FY2019 · AI
Elucidation of a bacterial cell shape generating program and pathogenic functions
$423,554Nina Reda Salama · Fred Hutchinson Cancer Research Center · R01 · FY2012 · AI
Determining the Efficacy of a Novel Apatite-Based Antimicrobial Bone Scaffold for Craniofacial Surgical Applications
$423,500Sujee Jeyapalina · University Of Utah · R21 · FY2023 · DE
Antimicrobial peptides and antibiotic diffusion in sputum
$423,500Paul L Bollyky · Stanford University · R21 · FY2025 · AI
GENETIC REQUIREMENTS OF HELICOBACTER PYLORI INFECTION
$423,477Nina Reda Salama · Fred Hutchinson Cancer Research Center · R01 · FY2010 · AI
Using gonococcal TonB-dependent transporters as vaccine antigens
$423,374Cynthia Nau Cornelissen · Georgia State University · U19 · FY2022 · AI
Broad spectrum Tricyclics GyrB, ParE inhibitors for antibacterial applications
$423,312Kenneth Bartizal · Rbhs-New Jersey Medical School · U19 · FY2016 · AI
Role of PrrF and PrrH regulation in Pseudomonas aeruginosa pathogenesis
$423,247Amanda Gail Oglesby · University Of Maryland Baltimore · R01 · FY2020 · AI
Peptide Based Antibacterial Coating
$423,190Jennifer Ann Neff · Allvivo Vascular, Inc. · R44 · FY2008 · DK
Selective Modulation of Neutrophils in Critical Illness
$423,179Craig Thomas Lefort · Rhode Island Hospital · R35 · FY2025 · GM
Discovery and characterization of synthetic bioinformatic natural product anticancer agents
$423,140Sean F Brady · Rockefeller University · R01 · FY2025 · CA
Discovery and characterization of synthetic bioinformatic natural product anticancer agents
$423,140Sean F Brady · Rockefeller University · R01 · FY2023 · CA
Reduction of Uneccessary Antibiotics in Adults by the Use of Viral Diagnostics
$423,110Ann R Falsey · University Of Rochester · R01 · FY2011 · AI
Wall Teichoic Acid Biosynthesis: A New Target for Therapeutic Intervention?
$422,813Suzanne L. Walker · Harvard Medical School · R01 · FY2007 · GM
PHOSPHONIC ACID BIOSYNTHETIC PATHWAYS
$422,754William W. Metcalf · University Of Illinois At Urbana-Champaign · P01 · FY2014 · GM
PHOSPHONIC ACID BIOSYNTHETIC PATHWAYS
$422,754William W. Metcalf · University Of Illinois At Urbana-Champaign · P01 · FY2015 · GM
PHOSPHONIC ACID BIOSYNTHETIC PATHWAYS
$422,753William W. Metcalf · University Of Illinois At Urbana-Champaign · P01 · FY2016 · GM
Drosophila melanogaster as a model host for Vibrio cholerae
$422,500Paula I Watnick · Boston Children'S Hospital · R01 · FY2007 · AI